HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 411967Generated: October 30, 2026
Sodium Iodide → Dibenzo[b,e][1,4]oxazepine
https://huagongshe.com/reaction/411967
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium Iodide | HCID 5238 | — |
| Reactant | Sodium Carbonate | HCID 10340 | — |
| Reactant | 2-[4-(N-t-butoxycarbonylamino)phenyl]ethyl chloride | HCID 18534774 | — |
| Reactant | (r)-5,11-Dihydro-5-(2-pyrrolidinylmethyl)dibenzo[b,e][1,4]oxazepine | HCID 69200761 | — |
| Solvent | Acetonitrile | HCID 6342 | — |
| Product | Dibenzo[b,e][1,4]oxazepine | HCID 21955449 | — |
Reaction Steps
(R)-5,11-dihydro-5-(2-pyrrolidinylmethyl)dibenzo[b,e][1,4]oxazepine (Preparation Example 1) (220 mg, 0.78 mmol), 2-[4-(N-t-butoxycarbonylamino)phenyl]ethyl chloride (400 mg, 1.02 mmol), sodium carbonate (110 mg, 1.02 mmol) and sodium iodide (20 mg, 0.13 mmol) were added to acetonitrile (15 ml), and the mixture was heated under reflux at 90° C. for 15 hours. The solvent was evaporated under reduced pressure, and the residue was partitioned in ethyl acetate and water. The organic layer was washed with water and then dried over magnesium sulfate. The solvent was evaporated under reduced pressure. The residue was treated by the column chromatography and then eluted with dichloromethane as the eluent. A suitable fraction was collected, and the solvent was evaporated under reduced pressure to obtain (R)-5,11-dihydro-5-[1-[2-(4-N-t-butoxycarbonylamino)phenyl)ethyl]-2-pyrrolidinylmethyl]dibenzo[b,e][1,4]oxazepine in the form of a light yellow oil (380 mg, 97%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06562808B1 |
|---|
| Source dataset | uspto-grants-2003_05 |
|---|
| ORD ID | ord-1ad6b1780c8b4afb8adbc9bfa8e99d2c |
|---|
| Source note | uspto-grants-2003_05 |
|---|